Similar hemostatic responses to hypovolemia induced by hemorrhage and lower body negative pressure reveal a hyperfibrinolytic subset of non-human primates.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
30
12
2019
accepted:
18
05
2020
entrez:
25
6
2020
pubmed:
25
6
2020
medline:
9
9
2020
Statut:
epublish
Résumé
To study central hypovolemia in humans, lower body negative pressure (LBNP) is a recognized alternative to blood removal (HEM). While LBNP mimics the cardiovascular responses of HEM in baboons, similarities in hemostatic responses to LBNP and HEM remain unknown in this species. Thirteen anesthetized baboons were exposed to progressive hypovolemia by HEM and, four weeks later, by LBNP. Hemostatic activity was evaluated by plasma markers, thromboelastography (TEG), flow cytometry, and platelet aggregometry at baseline (BL), during and after hypovolemia. BL values were indistinguishable for most parameters although platelet count, maximal clot strength (MA), protein C, thrombin anti-thrombin complex (TAT), thrombin activatable fibrinolysis inhibitor (TAFI) activity significantly differed between HEM and LBNP. Central hypovolemia induced by either method activated coagulation; TEG R-time decreased and MA increased during and after hypovolemia compared to BL. Platelets displayed activation by flow cytometry; platelet count and functional aggregometry were unchanged. TAFI activity and protein, Factors V and VIII, vWF, Proteins C and S all demonstrated hemodilution during HEM and hemoconcentration during LBNP, whereas tissue plasminogen activator (tPA), plasmin/anti-plasmin complex, and plasminogen activator inhibitor-1 did not. Fibrinolysis (TEG LY30) was unchanged by either method; however, at BL, fibrinolysis varied greatly. Post-hoc analysis separated baboons into low-lysis (LY30 <2%) or high-lysis (LY30 >2%) whose fibrinolytic state matched at both HEM and LBNP BL. In high-lysis, BL tPA and LY30 correlated strongly (r = 0.95; P<0.001), but this was absent in low-lysis. In low-lysis, BL TAFI activity and tPA correlated (r = 0.88; P<0.050), but this was absent in high-lysis. Central hypovolemia induced by either LBNP or HEM resulted in activation of coagulation; thus, LBNP is an adjunct to study hemorrhage-induced pro-coagulation in baboons. Furthermore, this study revealed a subset of baboons with baseline hyperfibrinolysis, which was strongly coupled to tPA and uncoupled from TAFI activity.
Sections du résumé
BACKGROUND
To study central hypovolemia in humans, lower body negative pressure (LBNP) is a recognized alternative to blood removal (HEM). While LBNP mimics the cardiovascular responses of HEM in baboons, similarities in hemostatic responses to LBNP and HEM remain unknown in this species.
METHODS
Thirteen anesthetized baboons were exposed to progressive hypovolemia by HEM and, four weeks later, by LBNP. Hemostatic activity was evaluated by plasma markers, thromboelastography (TEG), flow cytometry, and platelet aggregometry at baseline (BL), during and after hypovolemia.
RESULTS
BL values were indistinguishable for most parameters although platelet count, maximal clot strength (MA), protein C, thrombin anti-thrombin complex (TAT), thrombin activatable fibrinolysis inhibitor (TAFI) activity significantly differed between HEM and LBNP. Central hypovolemia induced by either method activated coagulation; TEG R-time decreased and MA increased during and after hypovolemia compared to BL. Platelets displayed activation by flow cytometry; platelet count and functional aggregometry were unchanged. TAFI activity and protein, Factors V and VIII, vWF, Proteins C and S all demonstrated hemodilution during HEM and hemoconcentration during LBNP, whereas tissue plasminogen activator (tPA), plasmin/anti-plasmin complex, and plasminogen activator inhibitor-1 did not. Fibrinolysis (TEG LY30) was unchanged by either method; however, at BL, fibrinolysis varied greatly. Post-hoc analysis separated baboons into low-lysis (LY30 <2%) or high-lysis (LY30 >2%) whose fibrinolytic state matched at both HEM and LBNP BL. In high-lysis, BL tPA and LY30 correlated strongly (r = 0.95; P<0.001), but this was absent in low-lysis. In low-lysis, BL TAFI activity and tPA correlated (r = 0.88; P<0.050), but this was absent in high-lysis.
CONCLUSIONS
Central hypovolemia induced by either LBNP or HEM resulted in activation of coagulation; thus, LBNP is an adjunct to study hemorrhage-induced pro-coagulation in baboons. Furthermore, this study revealed a subset of baboons with baseline hyperfibrinolysis, which was strongly coupled to tPA and uncoupled from TAFI activity.
Identifiants
pubmed: 32579572
doi: 10.1371/journal.pone.0234844
pii: PONE-D-19-35990
pmc: PMC7314422
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0234844Subventions
Organisme : NIH HHS
ID : P51 OD011133
Pays : United States
Déclaration de conflit d'intérêts
While author C.B. is currently employed by Charles Rivers Laboratories, this commercial affiliation does not alter our adherence to PLOS ONE policies on sharing data and materials from this current manuscript. All other authors have no competing interests.
Références
Am J Physiol Regul Integr Comp Physiol. 2016 Jun 1;310(11):R1154-9
pubmed: 27030667
J Trauma Acute Care Surg. 2017 Dec;83(6):1014-1022
pubmed: 29190254
J Trauma Acute Care Surg. 2016 Jan;80(1):16-23; discussion 23-5
pubmed: 26491796
Clin Physiol Funct Imaging. 2009 Nov;29(6):427-30
pubmed: 19656165
PLoS One. 2014 Dec 29;9(12):e116174
pubmed: 25546432
Eur J Haematol. 2000 Dec;65(6):357-69
pubmed: 11168493
Platelets. 2015;26(8):730-5
pubmed: 25549285
Blood Coagul Fibrinolysis. 2014 Sep;25(6):592-6
pubmed: 24732173
J Trauma Acute Care Surg. 2014 Dec;77(6):811-7; discussion 817
pubmed: 25051384
J Appl Physiol (1985). 2014 Jul 15;117(2):131-41
pubmed: 24876357
PLoS One. 2012;7(8):e42221
pubmed: 22876309
J Appl Physiol (1985). 2019 May 1;126(5):1214-1222
pubmed: 30763159
Br J Haematol. 2008 Oct;143(2):180-90
pubmed: 18783400
J Appl Physiol (1985). 2014 Feb 15;116(4):406-15
pubmed: 24356525
Thromb Haemost. 2006 Dec;96(6):781-8
pubmed: 17139373
J Appl Physiol (1985). 2015 Sep 15;119(6):677-85
pubmed: 26139213
Anaesth Intensive Care. 2003 Feb;31(1):40-3
pubmed: 12635393
J Appl Physiol (1985). 2004 Apr;96(4):1249-61
pubmed: 15016789
Physiol Rev. 2019 Jan 1;99(1):807-851
pubmed: 30540225
Blood Rev. 1993 Mar;7(1):52-62
pubmed: 8467233
Exp Physiol. 2016 Oct 1;101(10):1265-1275
pubmed: 27520090
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1591-7
pubmed: 26371166
Eur Neuropsychopharmacol. 2018 Jun;28(6):701-709
pubmed: 29699723